1. Home
  2. TRML vs JILL Comparison

TRML vs JILL Comparison

Compare TRML & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • JILL
  • Stock Information
  • Founded
  • TRML 2021
  • JILL 1959
  • Country
  • TRML United States
  • JILL United States
  • Employees
  • TRML N/A
  • JILL N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • JILL Clothing/Shoe/Accessory Stores
  • Sector
  • TRML Health Care
  • JILL Consumer Discretionary
  • Exchange
  • TRML Nasdaq
  • JILL Nasdaq
  • Market Cap
  • TRML 419.1M
  • JILL 375.1M
  • IPO Year
  • TRML N/A
  • JILL 2017
  • Fundamental
  • Price
  • TRML $23.01
  • JILL $26.29
  • Analyst Decision
  • TRML Strong Buy
  • JILL Strong Buy
  • Analyst Count
  • TRML 3
  • JILL 7
  • Target Price
  • TRML $65.00
  • JILL $38.17
  • AVG Volume (30 Days)
  • TRML 187.7K
  • JILL 97.1K
  • Earning Date
  • TRML 11-07-2024
  • JILL 12-03-2024
  • Dividend Yield
  • TRML N/A
  • JILL 1.06%
  • EPS Growth
  • TRML N/A
  • JILL 36.69
  • EPS
  • TRML N/A
  • JILL 2.83
  • Revenue
  • TRML N/A
  • JILL $614,539,000.00
  • Revenue This Year
  • TRML N/A
  • JILL $3.03
  • Revenue Next Year
  • TRML N/A
  • JILL $3.57
  • P/E Ratio
  • TRML N/A
  • JILL $9.30
  • Revenue Growth
  • TRML N/A
  • JILL 1.62
  • 52 Week Low
  • TRML $12.12
  • JILL $23.06
  • 52 Week High
  • TRML $48.31
  • JILL $40.61
  • Technical
  • Relative Strength Index (RSI)
  • TRML 37.25
  • JILL 58.42
  • Support Level
  • TRML $25.58
  • JILL $24.04
  • Resistance Level
  • TRML $27.51
  • JILL $27.12
  • Average True Range (ATR)
  • TRML 1.81
  • JILL 0.83
  • MACD
  • TRML -0.61
  • JILL 0.06
  • Stochastic Oscillator
  • TRML 10.76
  • JILL 73.93

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About JILL J. Jill Inc.

J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.

Share on Social Networks: